Marcus Krüger

Prof. Dr. Marcus Krüger

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2025 in Life
Verified
Journal Article
Open access
PDF file
JYJosef Yayan
Josef Yayan
CBChristian Biancosino
Christian Biancosino
MKMarcus Krüger
Marcus Krüger
KRKurt med. Kurt Rasche
Kurt med. Kurt Rasche
Background: Inflammation and nutritional status are known to affect outcomes in patients with chronic obstructive pulmonary disease (COPD). However, their prognostic relevance in critically ill COPD patients remains unclear. This study investigated whether C-reactive protein (CRP), serum albumin, and the CRP/albumin ratio (CAR) were associated with in-hospital mortality in ICU patients with COPD. Methods: We conducted a retrospective cohort study using data from the MIMIC-IV database. Adult ICU patients with a diagnosis of COPD were included. We analyzed CRP, albumin, CAR, glucose, lactate, and creatinine. The primary outcome was in-hospital mortality. Multivariable logistic regression was used to identify variables that were independently associated with in-hospital mortality. Subgroup analyses stratified by age and sex were performed. Results: We included 1000 ICU patients with COPD. In-hospital mortality was 19.6%. In univariate analyses, glucose, creatinine, and lactate levels were significantly higher in non-survivors. In multivariable models, only elevated creatinine (OR 1.60, 95% CI 1.01–2.53) remained independently associated with mortality, while glucose was no longer statistically significant. CRP, albumin, and CAR were not significantly associated with in-hospital mortality. Subgroup analyses showed consistent results across age and sex strata. Conclusion: In critically ill COPD patients, glucose and creatinine levels upon ICU admission were independently associated with in-hospital mortality, whereas inflammation- and nutrition-related markers, such as CRP, albumin, and CAR, were not. However, given that albumin is heavily influenced by systemic inflammation, it cannot serve as a standalone nutritional marker in the ICU setting. Composite nutritional scores such as the Nutritional Risk Screening (NRS-2002) or the Global Leadership Initiative on Malnutrition (GLIM), which were not available in the MIMIC-IV database, may provide more accurate assessments. These findings highlight the need for integrated risk models incorporating metabolic and renal parameters for early prognostication.

23 April 2021
Verified
Book Chapter
Closed access
PDF file
MKMarcus Krüger
Marcus Krüger
KFKatharina Franzke
Katharina Franzke
TRTaufiek Konrad Rajab
Taufiek Konrad Rajab
FNFabian Nadler
Fabian Nadler
MMMoritz Möbius-Winkler
Moritz Möbius-Winkler
CBChristian Biancosino
Christian Biancosino

18 November 2021
Verified
Book Chapter
Closed access
PDF file
CBChristian Biancosino
Christian Biancosino
LLLea Isabell Shari van der Linde
Lea Isabell Shari van der Linde
GSGuido Sauter
Guido Sauter
FSFlorian Stellmacher
Florian Stellmacher
MKMarcus Krüger
Marcus Krüger
PWPD Dr. med. Lutz Welker
PD Dr. med. Lutz Welker

31 December 2021
Verified
Book Chapter
Closed access
PDF file
CBChristian Biancosino
Christian Biancosino
LLLea Isabell Shari van der Linde
Lea Isabell Shari van der Linde
MKMarcus Krüger
Marcus Krüger
SHShuaib Hussam
Shuaib Hussam
FSFlorian Stellmacher
Florian Stellmacher
PWPD Dr. med. Lutz Welker
PD Dr. med. Lutz Welker

26 May 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
JYJosef Yayan
Josef Yayan
CBChristian Biancosino
Christian Biancosino
MKMarcus Krüger
Marcus Krüger
KRKurt med. Kurt Rasche
Kurt med. Kurt Rasche
Background: Chest radiography remains a cornerstone of thoracic imaging; however, the influence of patient demographics and technical factors on radiologic findings is not yet fully understood. This study investigates how gender, age, and radiographic projection affect the prevalence of three common findings: atelectasis, pleural effusion, and pulmonary nodules. Methods: We analyzed 112,120 frontal chest radiographs from the publicly available NIH ChestX-ray8 dataset. Gender-specific prevalence rates were compared using chi-square tests and unadjusted odds ratios (ORs). Multivariable logistic regression was performed to assess the independent effects of gender, age, and projection (posteroanterior [PA] vs. anteroposterior [AP]), including interaction terms. Results: Atelectasis and nodules were more prevalent in male patients, with unadjusted rates of 10.9% and 5.8% versus 9.5% and 5.4% in females. While the difference in nodules’ prevalence was not statistically significant (OR = 0.96, p = 0.16), multivariable analysis showed a significant association (adjusted OR = 1.378, 95% CI 1.157–1.641; p = 0.0003). Pleural effusion showed no significant gender difference (11.7% vs. 12.1%; OR 0.97, p = 0.10). Increasing age was consistently associated with higher odds of all findings (ORs per year: 1.016–1.012; all p < 0.0001). The PA view reduced the odds of atelectasis (OR 0.59) and effusion (OR 0.60), but increased the odds of detecting nodules (OR 1.31). Interaction terms showed minor but statistically significant gender-related differences in age effects. Conclusions: Gender, age, and radiographic projection substantially affect the radiographic detection of frequently observed thoracic abnormalities. These findings are directly relevant for improving clinical diagnostic accuracy and for reducing demographic and technical biases in AI-based radiograph interpretation, particularly in critical care and screening settings.

5 October 2025 in Medical Sciences
Verified
Journal Article
Open access
PDF file
JYJosef Yayan
Josef Yayan
CBChristian Biancosino
Christian Biancosino
MKMarcus Krüger
Marcus Krüger
KRKurt med. Kurt Rasche
Kurt med. Kurt Rasche
Background: Trelegy Ellipta is a widely prescribed triple inhaler therapy for chronic obstructive pulmonary disease (COPD). Although its clinical efficacy is well established, evidence on sex-specific differences in adverse event (AE) profiles from real-world pharmacovigilance data remains limited. In addition, some AEs may reflect underlying disease characteristics rather than drug exposure, which complicates interpretation of safety signals. Objective: To explore sex-related differences in AEs associated with Trelegy Ellipta using the FDA Adverse Event Reporting System (FAERS). The study aimed to identify potential safety signals while accounting for alternative explanations, including comorbidity burden and disease-related variation. Methods: We retrospectively analyzed FAERS reports from January 2018 to April 2025, identifying 4555 AEs attributed to Trelegy Ellipta. Events were coded by System Organ Class (SOC) and stratified by patient sex. Frequencies were compared between male (n = 1621) and female (n = 2934) patients using chi-square tests, and associations were expressed as reporting odds ratios (RORs) with 95% confidence intervals (CIs). Results: Male patients more frequently reported hypertension (63.4% vs. 47.0%; p = 0.01), pneumonia (87.8% vs. 76.8%; p < 0.001), anxiety (91.0% vs. 66.9%; p < 0.001), sleep disorders (20.1% vs. 6.8%; p < 0.001), and hyperglycemia (92.7% vs. 52.1%; p < 0.001). Female patients more often reported headache (56.7% vs. 32.6%; p < 0.001), depression (33.1% vs. 9.0%; p < 0.001), and osteoporosis (41.7% vs. 2.4%; p < 0.001). Further variation was observed across neurological, musculoskeletal, and respiratory categories, suggesting a multidimensional pattern of sex differences. Conclusions: This FAERS-based analysis indicates distinct sex-specific safety signals for Trelegy Ellipta, particularly in cardiovascular, neuropsychiatric, and steroid-related domains. These findings are hypothesis-generating and highlight the importance of incorporating sex-disaggregated analyses into future pharmacovigilance and clinical studies.